Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11913027
Methods of treatment using pluripotent human adipose adult stem cells
granted -
US 11903973
Genetically engineered hematopoietic stem cells and uses thereof
granted -
US 11903967
Method of preparing T cells with increased activity
granted -
US 11898166
In vitro generation of thymic organoid from human pluripotent stem cells
granted -
US 11898165
Engineered host cells and methods of use thereof
granted -
US 11891628
Method for biomimetic culture of urothelial cells and uses thereof
granted -
US 11891626
Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue
granted -
US 11885807
Method for depleting malignant T-cells
granted -
US 11884932
In vitro production of medial ganglionic eminence precursor cells
granted -
US 11883431
T-cells modified to overexpress PHF19
granted -
US 11885806
Method for depleting malignant T-cells
granted -
US 11865157
Compositions and methods of targeting cancer stem cells
granted -
US 11866794
Cas-ready mouse embryonic stem cells and mice and uses thereof
granted -
US 11858884
Compositions and methods for modulating gene or gene product in cells
granted -
US 11857574
Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11851680
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11851672
CAR T-cells comprising transcriptional circuits
granted -
US 11850261
Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells
granted -
US 11851677
Composition and methods for inducing myeloid suppressive cells and use thereof
granted -
US 11839631
Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
granted -
US 11839596
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11840575
Engineered immune cells targeting BCMA and their uses thereof
granted -
US 11801265
Preparation method of NK cells and use thereof in the treatment of cancer
granted -
US 11802272
Enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations
granted